Contents
- 📚 Introduction to Journal of Clinical Oncology
- 🔬 Research Focus and Scope
- 📆 Publication History and Frequency
- 👥 Editorial Team and Leadership
- 📊 Impact Factor and Citation Metrics
- 🌐 Global Reach and Accessibility
- 📝 Manuscript Submission and Peer Review
- 📰 Recent Developments and Controversies
- 👨🎓 Education and Training Opportunities
- 🤝 Collaborations and Partnerships
- 📊 Funding and Support
- 🔜 Future Directions and Prospects
- Frequently Asked Questions
- Related Topics
Overview
The Journal of Clinical Oncology is a peer-reviewed medical journal published by the American Society of Clinical Oncology (ASCO). First published in 1983, it has become a leading publication in the field of cancer research and treatment, with a focus on innovative and high-impact studies. The journal publishes original research articles, review articles, and editorials on all aspects of cancer, including prevention, diagnosis, treatment, and survivorship. With a vibe score of 8, the Journal of Clinical Oncology is widely regarded as a trusted source of information for oncologists, researchers, and other healthcare professionals. The journal has a controversy spectrum of 6, reflecting debates and discussions on topics such as cancer screening, treatment guidelines, and access to care. Notable contributors include Dr. Vincent DeVita, Dr. Samuel Hellman, and Dr. George P. Canellos, who have shaped the field of oncology through their research and publications. The journal's influence flows can be seen in its impact on clinical practice, policy, and future research directions, with a topic intelligence that encompasses key people, events, and ideas in the field.
📚 Introduction to Journal of Clinical Oncology
The Journal of Clinical Oncology is a premier peer-reviewed medical journal published 3 times a month by ASCO Publications. It covers research on all aspects of clinical oncology, including cancer research, oncology treatments, and cancer care. The journal was established in 1983 and has since become a leading source of information for oncologists, researchers, and other healthcare professionals. With its high impact factor and rigorous peer-review process, the Journal of Clinical Oncology is a trusted resource for staying up-to-date on the latest developments in the field. The journal's editor-in-chief, Jonathan W. Friedberg, is a renowned expert in the field of hematology and oncology.
🔬 Research Focus and Scope
The Journal of Clinical Oncology has a broad research focus, covering all aspects of clinical oncology, including cancer biology, cancer genetics, and cancer epidemiology. The journal publishes original research articles, review articles, and editorials on topics such as cancer treatment, cancer prevention, and cancer survivorship. With its strong focus on translational research, the journal aims to bridge the gap between laboratory research and clinical practice. The journal's scope also includes palliative care, supportive care, and quality of life issues in cancer patients. The journal's research focus is closely aligned with the goals of the American Society of Clinical Oncology (ASCO).
📆 Publication History and Frequency
The Journal of Clinical Oncology has a long publication history, dating back to 1983. The journal is published 3 times a month, with a total of 36 issues per year. The journal's publication frequency allows for timely dissemination of research findings and ensures that readers stay up-to-date on the latest developments in the field. The journal's publisher, ASCO Publications, is a leading publisher of medical journals and books in the field of oncology. The journal's online version is available on the ASCO website, and articles can be accessed through various academic databases such as PubMed and Scopus.
👥 Editorial Team and Leadership
The Journal of Clinical Oncology has a strong editorial team, led by editor-in-chief Jonathan W. Friedberg. The journal's editorial board consists of renowned experts in the field of oncology, including medical oncologists, surgical oncologists, and radiation oncologists. The journal's editors are responsible for ensuring the quality and integrity of the research published in the journal. The journal's editorial process involves rigorous peer review, with articles reviewed by at least two independent reviewers. The journal's editorial team also includes a team of associate editors, who assist with the review process and provide input on the journal's content. The journal's editors are committed to maintaining the highest standards of editorial integrity and transparency.
📊 Impact Factor and Citation Metrics
The Journal of Clinical Oncology has a high impact factor, indicating its reputation and influence in the field of oncology. The journal's impact factor is calculated by Thomson Reuters and is based on the number of citations received by articles published in the journal. The journal's impact factor is closely watched by researchers and institutions, and is often used as a metric for evaluating the quality of research. The journal's citation metrics also include the Eigenfactor score and the Article Influence Score. The journal's high impact factor reflects its commitment to publishing high-quality research that advances the field of oncology. The journal's impact factor is also influenced by its strong social media presence, with articles often being shared and discussed on platforms such as Twitter and Facebook.
🌐 Global Reach and Accessibility
The Journal of Clinical Oncology has a global reach, with articles published in the journal being accessed by researchers and healthcare professionals from around the world. The journal's online version is available in multiple languages, including English, Spanish, and Chinese. The journal's global reach is also facilitated by its partnerships with international organizations, such as the International Union Against Cancer (UICC). The journal's articles are also indexed in major academic databases, making them easily accessible to researchers and healthcare professionals. The journal's global reach is a testament to its reputation as a leading source of information on clinical oncology. The journal's global influence is also reflected in its Vibe Score, which measures the journal's cultural energy and impact.
📝 Manuscript Submission and Peer Review
The Journal of Clinical Oncology has a rigorous manuscript submission and peer review process, ensuring that only high-quality research is published in the journal. The journal accepts original research articles, review articles, and editorials, and all submissions are reviewed by at least two independent reviewers. The journal's editors use a blinded peer review process, where reviewers' identities are not disclosed to authors. The journal's editorial team also uses a variety of tools and software to detect plagiarism and ensure the integrity of the research. The journal's manuscript submission process is facilitated by its online submission system, which allows authors to easily submit their manuscripts and track the status of their submissions. The journal's peer review process is also supported by its Peer Review Policy, which outlines the journal's guidelines and procedures for peer review.
📰 Recent Developments and Controversies
The Journal of Clinical Oncology has been at the center of several recent developments and controversies in the field of oncology. One of the most significant controversies has been the debate over the use of immunotherapy in cancer treatment. The journal has published several articles on this topic, including a recent review article on the use of checkpoint inhibitors in cancer treatment. The journal has also published articles on the topic of precision medicine, including a recent study on the use of genomic sequencing in cancer diagnosis. The journal's coverage of these topics has been widely discussed and debated in the oncology community, and has helped to shape the conversation around these important issues. The journal's influence on the field of oncology is also reflected in its Influence Flow, which measures the journal's impact on the development of new ideas and research.
👨🎓 Education and Training Opportunities
The Journal of Clinical Oncology offers a range of education and training opportunities for healthcare professionals and researchers. The journal's website features a range of educational resources, including CME courses, webinars, and podcasts. The journal also offers a range of training programs and fellowships, including the ASCO Fellowship program. The journal's education and training programs are designed to help healthcare professionals stay up-to-date on the latest developments in the field of oncology, and to provide them with the skills and knowledge they need to provide high-quality care to their patients. The journal's education and training programs are also supported by its Education Policy, which outlines the journal's guidelines and procedures for education and training.
🤝 Collaborations and Partnerships
The Journal of Clinical Oncology has a range of collaborations and partnerships with other organizations and institutions in the field of oncology. The journal partners with organizations such as the National Cancer Institute (NCI) and the American Cancer Society (ACS) to promote cancer research and education. The journal also partners with international organizations, such as the International Union Against Cancer (UICC), to promote global cancer control and prevention. The journal's collaborations and partnerships help to advance the field of oncology and improve outcomes for cancer patients. The journal's partnerships are also reflected in its Entity Relationships, which map the journal's connections to other organizations and institutions in the field of oncology.
📊 Funding and Support
The Journal of Clinical Oncology is supported by a range of funding sources, including ASCO Publications and the National Cancer Institute (NCI). The journal also receives funding from private foundations and organizations, such as the American Cancer Society (ACS). The journal's funding sources help to support its editorial and publishing activities, and enable it to provide high-quality research and education to the oncology community. The journal's funding model is also supported by its Funding Policy, which outlines the journal's guidelines and procedures for funding and support.
🔜 Future Directions and Prospects
The Journal of Clinical Oncology is poised for future growth and development, with a range of new initiatives and projects in the pipeline. The journal is planning to launch a new open access section, which will feature articles that are freely available to readers. The journal is also planning to expand its social media presence, with a range of new social media channels and initiatives. The journal's future plans also include the development of new educational resources and training programs, including CME courses and webinars. The journal's future prospects are bright, and it is likely to remain a leading source of information on clinical oncology for years to come. The journal's future is also influenced by its Controversy Spectrum, which measures the level of debate and controversy surrounding the journal's topics and research.
Key Facts
- Year
- 1983
- Origin
- American Society of Clinical Oncology (ASCO)
- Category
- Medical Research
- Type
- Medical Journal
Frequently Asked Questions
What is the Journal of Clinical Oncology?
The Journal of Clinical Oncology is a peer-reviewed medical journal published 3 times a month by ASCO Publications. It covers research on all aspects of clinical oncology, including cancer research, oncology treatments, and cancer care. The journal was established in 1983 and has since become a leading source of information for oncologists, researchers, and other healthcare professionals.
Who is the editor-in-chief of the Journal of Clinical Oncology?
The editor-in-chief of the Journal of Clinical Oncology is Jonathan W. Friedberg. He is a renowned expert in the field of hematology and oncology, and has been instrumental in shaping the journal's content and direction.
What is the impact factor of the Journal of Clinical Oncology?
The Journal of Clinical Oncology has a high impact factor, indicating its reputation and influence in the field of oncology. The journal's impact factor is calculated by Thomson Reuters and is based on the number of citations received by articles published in the journal.
How can I submit a manuscript to the Journal of Clinical Oncology?
The Journal of Clinical Oncology accepts original research articles, review articles, and editorials. Manuscripts can be submitted online through the journal's website, and must be accompanied by a cover letter and other supporting materials. The journal's editorial team reviews all submissions, and only high-quality research is published in the journal.
What are the journal's education and training opportunities?
The Journal of Clinical Oncology offers a range of education and training opportunities for healthcare professionals and researchers. The journal's website features a range of educational resources, including CME courses, webinars, and podcasts. The journal also offers a range of training programs and fellowships, including the ASCO Fellowship program.
What are the journal's collaborations and partnerships?
The Journal of Clinical Oncology has a range of collaborations and partnerships with other organizations and institutions in the field of oncology. The journal partners with organizations such as the National Cancer Institute (NCI) and the American Cancer Society (ACS) to promote cancer research and education. The journal also partners with international organizations, such as the International Union Against Cancer (UICC), to promote global cancer control and prevention.
What is the journal's funding model?
The Journal of Clinical Oncology is supported by a range of funding sources, including ASCO Publications and the National Cancer Institute (NCI). The journal also receives funding from private foundations and organizations, such as the American Cancer Society (ACS). The journal's funding model is designed to support its editorial and publishing activities, and to enable it to provide high-quality research and education to the oncology community.